What recent price and volume should I note for 2228.HK stock?

Pre-market price is **HK$10.51** with volume **42,503,727.00** today. Day range is **HK$10.46–HK$10.77** and the 52-week range is **HK$3.85–HK$15.12**. Watch liquidity relative to the 50-day average.

How does Meyka AI view the 2228.HK stock outlook?

Meyka AI gives 2228.HK a **62.84/100 (B, HOLD)** score. The model flags a **quarterly target HK$13.19** (+25.50% upside) but notes valuation and margin risks. Grades are not guaranteed and not investment advice.

What are the main risks for investors in 2228.HK stock?

Key risks are high R&D spending, long sales cycles for drug discovery services, PB above sector average, and sensitivity to AI-biotech sentiment. Company-specific earnings and milestone execution drive large moves.

Where can I find official financials and company details for 2228.HK stock?

Primary sources include the company site [XtalPi](https://www.xtalpi.com) and financial summaries on [StockAnalysis](https://stockanalysis.com/quote/hkg/2228/). Use filings and quarterly reports for full detail.

HK Stocks

Pre-market HKSE 26 Feb 2026: 2228.HK XtalPi at HK$10.51, AI model shows 25.50% near-term upside

ByHuzaifa Zahoor February 26, 2026

The 2228.HK stock opens pre-market in Hong Kong at HK$10.51, down -1.41% from yesterday and trading lighter at 42,503,727.00 shares. We focus on how XtalPi Holdings Ltd (2228.HK) translates AI drug discovery progress into valuation signals. The company reports EPS HK$1.05 and a market cap of HK$45,228,437,208.00, while sector peers trade at higher average PE multiples. This note links financials, technicals, and AI-driven forecasts to a clear short- and medium-term outlook for traders and investors using Meyka AI market analysis tools.